Work

Bull's-Eyes and Blind Spots: Pre-Clinical Studies with the Allosteric Inhibitor ABL001 in BCR-ABL1 Compound Mutation-Based Resistance

Year: 2015

Type: article

Source: Blood

DOI: 10.1182/blood.v126.23.1565.1565

Authors: O'Hare Thomas, Matthew S. Zabriskie, Christopher A. Eide, Nadeem A. Vellore, Brian J. Druker, Michael W Deininger

Institutions: University of Utah, Huntsman Cancer Institute, Oregon Health & Science University, OHSU Knight Cancer Institute

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2979328576

FWCI:

Cites:

Cited by:

Related to: 10